AIM News and Press, AIM ImmunoTech Inc. From 08/19/20

ABINGDON, OXFORDSHIRE / ACCESSWIRE / August 19, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it has issued to certain US investors 500,000 American Depositary Sha...

Calgary, Alberta and Houston, Texas--(Newsfile Corp. - August 17, 2020) - PetroTal Corp. (TSXV: TAL) (AIM: PTAL) (" PetroTal " or the " Company ") is pleased to announce its financial and operating results for the six and three months ended June 30, 2020 ("Q2 2020"). Selected financial an...

LONDON, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc  (the "Company" or “Horizonte”) (AIM: HZM; TSX: HZM), the nickel development company focused in Brazil, is pleased to announce that it has today published its 2019 Sustainability Report. The report is an ov...

AIM ImmunoTech (NYSEMKT: AIM ) : Q2 GAAP EPS of -$0.11. More news on: AIM ImmunoTech Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

RNS Horizon Discovery Group plc Results for the Six Months Ended 30 June 2020 Cambridge, UK, 17 August 2020:  Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or “the Company”), a cell engineering company focused on commercialising the applicatio...

Phase 1/2a trial of Ampligen in combination with interferon alfa-2b in cancer patients with COVID-19 is on track for enrollment OCALA, FL / ACCESSWIRE / August 17, 2020 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics...

LONDON, UK / ACCESSWIRE / August 14, 2020 / Condor Gold plc ("Condor Gold", "Condor", the "Group" or the "Company"), (AIM:CNR)(TSX:COG) presents its unaudited interim financial report together with Management's Discussion and Analysis for the three- and six-month periods to 30 June 2020. Bo...

LONDON, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc,   (AIM: HZM; TSX: HZM) (the "Company" or “Horizonte”), the nickel development company focused on developing its ferro-nickel project in Brazil (“Araguaia” or “the Project”), an...

Completed $200 million private placement post period Phase 3 COPD clinical trials planned to start later this year Pilot clinical study in patients hospitalized with COVID-19 planned to start in the third quarter Conference Call Today at 9:00 am EDT / 2:00 pm BST LONDON an...

ABINGDON, OXFORDSHIRE / ACCESSWIRE / August 14, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that the U.S. Securities and Exchange Commission ("SEC") has declared e...